For someone with Alzheimer's disease, one of the first skills to decline is the high-level function required to accomplish financial tasks such as paying bills, balancing a checkbook or reading a brokerage statement.
Unfortunately, the number of Americans with Alzheimer's disease is expected to nearly triple by 2050. This epidemic will put even more pressure on financial advisors and stockbrokers to make sure they are not taking advantage of their clients.
According to a new government-funded report, which was published in the medical journal Neurology, the number of people suffering from this devastating disease will increase to 13.8 million over the next four decades, from 5 million today. Nearly half of those 85 and older are victims, according to the Alzheimer's Association.
Only a few federal, state or industry guidelines exist to help financial planners navigate the potential legal, ethical and practical challenges of dealing with clients who exhibit mild or moderate dementia.
Were your loved ones sold investments or asked to make financial decisions by their brokers or financial advisors while suffering from Alzheimer's disease? Call Soreide Law Group for a free consultation with an attorney at: 888-760-6552
Investors might have sustained financial harm through WestPark Capital Inc. [CRD: 39914, Los Angeles, California], according to publicly available information found on Financial Industry Regulatory Authority BrokerCheck. WestPark Capital has been registered with FINRA since 1996 and maintains its headquarters in Los Angeles, California. Keep reading to discover more about the regulatory action involving the […]
Investors might have sustained losses due to securities broker James Fredrick Tighe [CRD: 3129233, Phoenix, Arizona], and Financial Industry Regulatory Authority barred him, based on public information on BrokerCheck. Tighe was associated with Morgan Stanley from June 1, 2009, through January 14, 2025. Continue reading to find out more about Tighe’s regulatory and client dispute […]
Investors potentially experienced sales practice violations by securities broker Sung Moo Cho (also known as Sam Cho) [CRD: 5015906, New York, New York], and FINRA barred him, given the public information found on FINRA BrokerCheck. Cho was associated with Ameriprise Financial Services from January 22, 2021, to October 21, 2025, and Citigroup Global Markets from […]
Phone:
Fax: 1-954-760-6553
Email: info@securitieslawyer.com